Your session is about to expire
← Back to Search
Study Summary
This trial is testing a new drug to see if it is safe and effective in adults with asthma.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Frequently Asked Questions
Are new volunteers still able to register for this research endeavor?
"Affirmative. Clinicaltrials.gov data indicates that this trial, which was initially posted on December 16th 2021, is presently searching for participants. Approximately 240 patients must be recruited from 1 medical centre."
Has the United States Food and Drug Administration sanctioned AZD8630 for therapeutic use?
"Since this is a preliminary trial, our team at Power assigned AZD8630 a score of 1 since there is only scant evidence outlining its safety and efficacy."
What is the current enrollment rate for this clinical research project?
"Affirmative. On clinicaltrials.gov, it is shown that recruitment for this medical investigation began on December 16th 2021 and the latest update was November 16th 2022. This research requires 240 individuals to join from 1 site."
Is it a requirement that prospective participants in this research must be under the age of 65?
"This research trial is open to adults between the ages of 18 and 75. There are 113 studies for minors and 198 programs designed for elderly people."
What are the primary aims of this experiment?
"The primary outcome to be measured during the Pre-dose, Post-Dose (Days 1 - 4) and Follow Up/ET Visit (7 day post dose) time frames is the amount of participants with adverse events in Part A & B. Secondary objectives include assessing the Area under Plasma Concentration Time Curve divided by Lung Delivered Dose(AUCt/LDD), maximum serum concentration divided by lung delivered dose [Cmax/LDD] and area under serum concentration time curve (AUCt). All results will incorporate data from healthy individuals belonging to both Japanese and Chinese ethnicities."
Are there any particular demographics that are favored to participate in this research?
"This clinical trial seeks to recruit 240 individuals who are currently affected by asthma, ranging in age from 18-75. In addition to this criterion, Japanese participants must be between 20 and 55 years of age while Chinese participants have a lower limit of 18 but an upper limit of 45; any female enrollees will require negative pregnancy tests as well as confirmation that they are not lactating nor capable of bearing children followed by the use highly effective contraception for both them and their male partners. All prospective patients should fall within the BMI range of 18-35 kg/m^2 with a minimum weight requirement of 45kg; furthermore, those born in Japan"
Who else is applying?
What state do they live in?
How old are they?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger